Literature DB >> 21880961

Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB.

Scott R Curry1, Jessica L Schlackman, Travis M Hamilton, Tatianna K Henderson, Nakita T Brown, Jane W Marsh, Kathleen A Shutt, Maria M Brooks, A William Pasculle, Carlene A Muto, Lee H Harrison.   

Abstract

Active surveillance testing to identify and isolate asymptomatic carriers of toxigenic Clostridium difficile has been limited by the lack of a test that is sensitive, specific, and timely enough to serve as an infection control tool. We tested DNA preamplified from perirectal surveillance specimens in a liquid medium selective for C. difficile by using a modified commercial real-time PCR assay. All fermenting specimens were subcultured, and isolates were tested for toxigenicity. Culture-positive toxigenic isolates served as the gold standard for comparison with the broth preamplification/PCR assay. The limit of detection for the assay was 1 CFU. Relative to toxigenic anaerobic culture, the sensitivity, specificity, and positive and negative predictive values of this assay were 70/70 (100.0%), 422/426 (99.1%), 70/74 (94.6%), and 422/422 (100.0%), respectively. These data demonstrate that selective broth preamplification and real-time PCR of perirectal swab specimens constitute a practical approach to the detection of asymptomatic C. difficile carriage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880961      PMCID: PMC3209091          DOI: 10.1128/JCM.00679-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

2.  Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay.

Authors:  David K Warren; Robert S Liao; Liana R Merz; Michael Eveland; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

3.  Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program.

Authors:  Ann Huletsky; Pierre Lebel; Francois J Picard; Marthe Bernier; Martin Gagnon; Nathalie Boucher; Michel G Bergeron
Journal:  Clin Infect Dis       Date:  2005-03-04       Impact factor: 9.079

4.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

5.  tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile.

Authors:  Scott R Curry; Jane W Marsh; Carlene A Muto; Mary M O'Leary; A William Pasculle; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

6.  Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Authors:  Michelle M Riggs; Ajay K Sethi; Trina F Zabarsky; Elizabeth C Eckstein; Robin L P Jump; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

7.  Controlled evaluation of the IDI-MRSA assay for detection of colonization by methicillin-resistant Staphylococcus aureus in diverse mucocutaneous specimens.

Authors:  Nour de San; Olivier Denis; Marie-Fabrice Gasasira; Ricardo De Mendonça; Claire Nonhoff; Marc J Struelens
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

8.  Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens.

Authors:  Paul D Stamper; Wisal Babiker; Romina Alcabasa; Deborah Aird; Jennifer Wehrlin; Ijeoma Ikpeama; Linda Gluck; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

9.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

10.  Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea.

Authors:  Lance R Peterson; Rebecca U Manson; Suzanne M Paule; Donna M Hacek; Ari Robicsek; Richard B Thomson; Karen L Kaul
Journal:  Clin Infect Dis       Date:  2007-09-25       Impact factor: 9.079

View more
  18 in total

Review 1.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Sensitive and selective culture medium for detection of environmental Clostridium difficile isolates without requirement for anaerobic culture conditions.

Authors:  Jennifer L Cadnum; Kelly N Hurless; Abhishek Deshpande; Michelle M Nerandzic; Sirisha Kundrapu; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

3.  Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.

Authors:  Alison L Galdys; Jemma S Nelson; Kathleen A Shutt; Jessica L Schlackman; Diana L Pakstis; A William Pasculle; Jane W Marsh; Lee H Harrison; Scott R Curry
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

4.  Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test.

Authors:  Parul A Patel; Donna M Schora; Kamaljit Singh; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

5.  Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Authors:  Scott R Curry; Carlene A Muto; Jessica L Schlackman; A William Pasculle; Kathleen A Shutt; Jane W Marsh; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2013-07-23       Impact factor: 9.079

6.  Editorial Commentary: looking to the future: vertical vs horizontal prevention of Clostridium difficile infections.

Authors:  L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2013-07-23       Impact factor: 9.079

7.  Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.

Authors:  Curtis J Donskey; Venkata C K Sunkesula; Annette L Jencson; Nimalie D Stone; Carolyn V Gould; L Clifford McDonald; Matthew Samore; Jeanmarie Mayer; Susan Pacheco; Susan Sambol; Laurica Petrella; Deborah Terry; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

8.  A Novel Protocol Obviates Endoscope Sampling for Carbapenem-Resistant Enterobacteriaceae: Experience of a Center with a Prior Outbreak.

Authors:  Zachary L Smith; Arshish Dua; Kia Saeian; Nathan A Ledeboer; Mary Beth Graham; Murad Aburajab; Darren D Ballard; Abdul H Khan; Kulwinder S Dua
Journal:  Dig Dis Sci       Date:  2017-07-05       Impact factor: 3.199

9.  Evaluation of the Use of Rectal Swabs for Laboratory Diagnosis of Clostridium difficile Infection.

Authors:  N Jazmati; E Kirpal; E Piepenbrock; Y Stelzer; M J G T Vehreschild; H Seifert
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

Review 10.  A review of the economics of treating Clostridium difficile infection.

Authors:  Kari A Mergenhagen; Amy L Wojciechowski; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.